NCT06857890View on ClinicalTrials.gov

Safety, Tolerability, and Pharmacokinetic Profile of Grammidin With Anesthetic, a Metered Dose Topical Spray in Healthy Volunteers

PHASE1RecruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

December 9, 2024

Primary Completion Date

December 1, 2026

Study Completion Date

December 1, 2026

Conditions
Pharyngitis
Interventions
DRUG

Grammidin with anesthetic neo

Grammidin with anesthetic neo, lozenges, 1 lozenge to be taken once under fed conditions.

DRUG

Grammidin with anesthetic, a metered dose topical spray

Grammidin with anesthetic, a metered dose topical spray, 4 sprays to be taken once under fed conditions

Trial Locations (1)

Unknown

RECRUITING

"Separate Medical Unit CoMed (LLC Ligand Research)", Moscow

All Listed Sponsors
lead

Valenta Pharm JSC

INDUSTRY